🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the change in the expression of tr...
Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Start Date
2024-07-29
Trial ID
NCT06379217
The goal of this investigator-initiated single-site clinical trial is to co...
Status
Recruiting
Location
Main Line Health
Start Date
2024-08-15
Trial ID
NCT06439524
Treatments Being Tested
This phase II trial compares the usual treatment of radiation therapy alone...
Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2022-04-20
Trial ID
NCT05053152
The purpose of this research study is to test the efficacy of ADT on prosta...
Status
Recruiting
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2026-07-29
Trial ID
NCT07455903
This phase II trial tests how well pembrolizumab along with standard of car...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-16
Trial ID
NCT06528210
This phase II trial studies how well a short course of androgen deprivation...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-08-25
Trial ID
NCT07025369
The goal of this study is to evaluate the recovery of erectile function at ...
Status
Recruiting
Location
Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale - Napoli
Start Date
2026-02-23
Trial ID
NCT07302451
This phase II trial tests how well relugolix and enzalutamide, in combinati...
Status
Recruiting
Location
Northwestern University
Start Date
2024-09-06
Trial ID
NCT06499870
The mechanisms underlying variable efficacy of Relugolix-Combination Therap...
Status
Withdrawn
Location
NorthShore University HealthSystem
Start Date
2024-06-01
Trial ID
NCT06279195
Treatments Being Tested
This phase II trial evaluates the best duration for relugolix to be given i...
Status
Not Yet Recruiting
Location
University of Kansas Cancer Center
Start Date
2023-11-20
Trial ID
NCT06129851